ATTO (Attovia Therapeutics) Total Liabilities: $271.60 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ATTO Attovia Therapeutics Inc ATTO
8 GF Score
Price $20.38
View Full Analysis

What is Attovia Therapeutics Total Liabilities?

Attovia Therapeutics ATTO -6.94% 8 Total Liabilities is $271.60 Mil as of Mar. 2026. GuruFocus rates ATTO with a GF Score™ of 8/100.

Attovia Therapeutics's Total Liabilities for the quarter that ended in Mar. 2026 was $271.60 Mil.

Attovia Therapeutics's quarterly Total Liabilities increased from Mar. 2025 ($0.00 Mil) to Dec. 2025 ($273.33 Mil) but then declined from Dec. 2025 ($273.33 Mil) to Mar. 2026 ($271.60 Mil).

Attovia Therapeutics's annual Total Liabilities increased from . 20 ($0.00 Mil) to Dec. 2024 ($123.54 Mil) and increased from Dec. 2024 ($123.54 Mil) to Dec. 2025 ($273.33 Mil).

Attovia Therapeutics Total Liabilities Historical Data

* Premium members only.

The historical data trend for Attovia Therapeutics's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Attovia Therapeutics Total Liabilities Chart

Attovia Therapeutics Annual Data
Trend Dec24 Dec25
Total Liabilities
123.54 273.33

Attovia Therapeutics Quarterly Data
Dec24 Mar25 Dec25 Mar26
Total Liabilities 123.54 0.00 273.33 271.60
ATTO
8GF Score
Attovia Therapeutics Inc ATTO
Total Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Attovia Therapeutics Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Attovia Therapeutics's Total Liabilities for the fiscal year that ended in Dec. 2025 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=11.007+(3.341+258.981
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=273.33

Total Liabilities=Total Assets (A: Dec. 2025 )-Total Equity (A: Dec. 2025 )
=165.893--107.436
=273.33

Attovia Therapeutics's Total Liabilities for the quarter that ended in Mar. 2026 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=9.799+(2.826+258.976
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=271.60

Total Liabilities=Total Assets (Q: Mar. 2026 )-Total Equity (Q: Mar. 2026 )
=146.086--125.515
=271.60

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of $271.60 Mil mean?
Attovia Therapeutics (ATTO) has a Total Liabilities of $271.60 Mil as of Mar. 2026. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Attovia Therapeutics and its competitors.
Is Attovia Therapeutics' Total Liabilities too high?
Attovia Therapeutics' current Total Liabilities is $271.60 Mil. Overall, Attovia Therapeutics has a GF Score™ of 8/100, reflecting its overall financial health beyond just this single metric.
How does Attovia Therapeutics' Total Liabilities compare to ?
Attovia Therapeutics' Total Liabilities of $271.60 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Biotechnology company?
A good Total Liabilities depends on the Biotechnology industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Attovia Therapeutics and its competitors. Attovia Therapeutics's current Total Liabilities is $271.60 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Attovia Therapeutics stock overvalued right now?
Attovia Therapeutics (ATTO) has a current Total Liabilities of $271.60 Mil. The current Total Liabilities is $271.60 Mil. Attovia Therapeutics' overall GF Score™ is 8/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For Attovia Therapeutics (ATTO), the current Total Liabilities is $271.60 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Attovia Therapeutics Business Description

Comparable Companies
Attovia Therapeutics Inc is a clinical stage biotechnology company focused on research and development of therapeutic products in the fields of immune-mediated diseases. Its product pipeline includes ATTO-1310 and ATTO-2306 for immune-dermatology indications and ATTO-1091 for inflammatory diseases, including inflammatory bowel disease (IBD). The company's product candidates are developed using its ATTOBODY biologics platform.
8GF Score

Get the complete analysis for ATTO

Total Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$20.38
Price